One Bridget Dintwe

One Bridget Dintwe

One Bridget Dintwe

One Dintwe currently holds the position of Research Officer in the Cape Town HIV Vaccine Trials Network (HVTN) Immunology Laboratory (CHIL) located in South Africa.

As a doctoral fellow at the South African TB Vaccine Initiative, at the University of Cape Town, One Dintwe carried out research to understand the role that memory T cells play in protecting against TB disease. She was involved in developing new tools to identify and perform an in-depth characterization of TB-specific memory T cells developed after vaccination with a novel TB vaccine, MVA85A, which went into a phase III efficacy trial. In 2015, she joined the HIV Vaccine Trials Network (HVTN) where she has been working on HIV clinical trial endpoints using the intracellular cytokine staining assay to determine which vaccines to take further in clinical trials. Her laboratory assesses cellular and innate immune responses to HIV and TB vaccines using technologies such as flow cytometry, multiplex protein detection, and next-generation sequencing. The lab standardized qualify, and validated assays conducted in a Good Clinical Laboratory Practice (GCLP)-compliant environment and assured assay concordance with the sister HVTN laboratory at the Fred Hutch in Seattle. One Dintwe experience focuses on measuring human immune responses to HIV and TB, primarily by flow cytometry, and application of systems biology approaches to understand disease pathogenesis and immune correlates of risk or protection, which can ultimately facilitate development and assessment of new vaccine.

Deshnee Achary

Benjamin Watyaba

Benjamin Watyaba

Benjamin Watyaba

Benjamin Watyaba is a medical doctor and a researcher at Uganda Virus Research since 2021. He is currently coordinating two studies: Clinical Characterization of Protocol for Covid-19 disease and implementation of Point of Care HIV viral load monitoring in East Africa.

Benjamin Watyaba is also the deputy head of HIV work package in the Eastern Africa Consortium for Clinical Research, one of the nodes of excellence under European Developing Countries Trial Partnership (EDCTP).

From 2016 to 2020, I worked as a general practitioner at Mengo Hospital, Kampala Uganda. I was the focal person for Sickle cell clinic and head of GPs for two years.

Education

Benjamin Watyaba has just completed the international masters in Vaccinology (IMVACC) and successfully defended his thesis entitled: “Assessing knowledge and reporting of adverse events following immunization” He also completed his Bachelor of Medicine and Bachelor of Surgery degrees (MBChB) from Makerere University in 2015.

Deshnee Achary

Deshnee Achary

Deshnee Achary

a student of the International Master of Vaccinology (IMVACC) class 2021, working at Pfizer vaccines in Johannesburg South Africa, received an award from the former President of South Africa Thabo Mbeki and The University of South Africa Principal and Vice-Chancellor (VC), Professor Puleng LenkaBula, who honored her for the work she has done in vaccines for the past 17years.

In her thank you speech she spoke about empowerment through education, highlighting the importance of using the education for the greater of mankind “When you are educated you are empowered and encouraged, and you have the power to change your life, your community around you and most importantly you have the power to educate others.”

She also touched on the topic of vaccine resistance and hesitancy and how fake news miscommunication can lead to people making bad decisions about their health which leads to disease, increased burden on the healthcare system and increased mortality.

Deshnee Achary